Apyx Medical Corporation
APYX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56,156 | $90,710 | $80,767 | $440,136 |
| - Cash | $31,741 | $43,652 | $10,192 | $30,870 |
| + Debt | $38,764 | $38,501 | $796 | $305 |
| Enterprise Value | $63,179 | $85,559 | $71,371 | $409,571 |
| Revenue | $48,102 | $52,349 | $44,510 | $48,517 |
| % Growth | -8.1% | 17.6% | -8.3% | – |
| Gross Profit | $29,360 | $33,759 | $29,131 | $33,601 |
| % Margin | 61% | 64.5% | 65.4% | 69.3% |
| EBITDA | -$16,801 | -$18,112 | -$22,006 | -$13,907 |
| % Margin | -34.9% | -34.6% | -49.4% | -28.7% |
| Net Income | -$23,463 | -$18,713 | -$23,184 | -$15,172 |
| % Margin | -48.8% | -35.7% | -52.1% | -31.3% |
| EPS Diluted | -0.66 | -0.54 | -0.67 | -0.44 |
| % Growth | -22.2% | 19.4% | -52.3% | – |
| Operating Cash Flow | -$18,047 | -$5,249 | -$20,280 | -$10,449 |
| Capital Expenditures | -$722 | -$533 | -$1,010 | -$723 |
| Free Cash Flow | -$18,769 | -$5,782 | -$21,290 | -$11,172 |